Abstract
Rationale
Topiramate is an anticonvulsant currently under study for treating substance use disorders. Topiramate is thought to reduce substance use by attenuating craving and the rewarding effects of acute substance use through its concurrent GABAergic agonism and glutamatergic antagonism. Importantly, topiramate also impacts mood states central to many models of substance use. Despite this, little previous research has examined whether topiramate attenuates the respective associations of affect and craving with substance use.
Objectives
We conducted a secondary analysis of 63 youths that exhibited heavy cannabis use, aged 15–24 years, who were randomized in a double-blinded 6-week clinical trial comparing the effects of topiramate (up to 200 mg/day) and placebo on cannabis use. Ecological momentary assessment data were leveraged to model the role positive affect, negative affect, and craving on use over the 6-week period and whether topiramate attenuated associations between these feeling states and cannabis use.
Results
Findings showed that craving was positively associated with use at the within-person level, while positive affect was negatively associated with use at the between-person level. Topiramate appears to attenuate the negative association of between-person positive affect (i.e., average) and cannabis use. Specifically, those in the placebo condition exhibited this inverse association between average positive affect and use while those in topiramate condition did not. No other significant affect or affect × medication condition interactions were observed.
Conclusions
These findings implicate craving and low positive affect as important risk factors for cannabis use in youth in treatment. Topiramate may attenuate this association for positive affect.
Similar content being viewed by others
References
Aguinaldo LD, Squeglia LM, Gray KM, Coronado C, Lees B, Tomko RL, Jacobus J (2019) Behavioral treatments for adolescent cannabis use disorder: a rationale for cognitive retraining. Curr Addict Rep 6(4):437–442
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Author, Washington, DC. https://doi.org/10.1176/appi.books.9780890425596
Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111(1):33
Bottlender M, Soyka M (2004) Impact of craving on alcohol relapse during, and 12 months following, outpatient treatment. Alcohol Alcohol 39(4):357–361
Buckner JD, Crosby RD, Silgado J, Wonderlich SA, Schmidt NB (2012) Immediate antecedents of marijuana use: an analysis from ecological momentary assessment. J Behav Ther Exp Psychiatry 43(1):647–655
Buckner JD, Heimberg RG, Ecker AH, Vinci C (2013a) A biopsychosocial model of social anxiety and substance use. Depress Anxiety 30(3):276–284
Buckner JD, Zvolensky MJ, Ecker AH (2013b) Cannabis use during a voluntary quit attempt: an analysis from ecological momentary assessment. Drug Alcohol Depend 132(3):610–616
Campos M, Iraurgui J, Paez D, Velasco C (2004) Coping and emotional regulation of stress events. A meta-analysis of 13 studies. Boletin-De-Psicologia 82:25–44
Chassin L, Sher KJ, Hussong A, Curran P (2013) The developmental psychopathology of alcohol use and alcohol disorders: research achievements and future directions. Dev Psychopathol 25(4 Pt 2):1567–1584. https://doi.org/10.1017/S0954579413000771
Clark LA, Watson D, Mineka S (1994) Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 103(1):103–116. https://doi.org/10.1037/0021-843X.103.1.103
Colder CR, Chassin L (1997) Affectivity and impulsivity: temperament risk for adolescent alcohol involvement. Psychol Addict Behav 11(2):83–97. https://doi.org/10.1037/0893-164X.11.2.83
Colder CR, Chassin L, Lee MR, Villalta IK (2010) Developmental perspectives: affect and adolescent substance use. In Kassel JD (Ed.), Substance abuse and emotion. (pp. 109–135). Wsahington D.C.: American Psychological Association. https://doi.org/10.1037/12067-005
Davis JP, Smith DC, Briley DA (2017) Substance use prevention and treatment outcomes for emerging adults in non-college settings: a meta-analysis. Psychol Addict Behav 31(3):242
Deas D, Roberts J, Randall C, Anton R (2001) Adolescent obsessive-compulsive drinking scale: an assessment tool for problem drinking. J Natl Med Assoc 93(3):92–103
Deas D, Roberts JS, Grindlinger D (2005) The utility of DSM-IV criteria in diagnosing substance abuse/dependence in adolescents [article]. Journal of Substance Use 10(1):10–21. https://doi.org/10.1080/1465989042000271200
Del Boca FK, Kranzler HR, Brown J, Korner PF (1996) Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 20(8):1412–1417. https://doi.org/10.1111/j.1530-0277.1996.tb01142.x
Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, Liddle H, Titus JC, Kaminer Y, Webb C (2004) The cannabis youth treatment (CYT) study: main findings from two randomized trials. J Subst Abuse Treat 27(3):197–213
Donovan DM, Marlatt GA (2005) Assessment of addictive behaviors, 2nd edn. In: Donovan DM, Marlatt GA (eds). The Guilford Press, New York
Dulin PL, Gonzalez VM (2017) Smartphone-based, momentary intervention for alcohol cravings amongst individuals with an alcohol use disorder. Psychol Addict Behav 31(5):601–607. https://doi.org/10.1037/adb0000292
Dunn TJ, Baguley T, Brunsden V (2014) From alpha to omega: a practical solution to the pervasive problem of internal consistency estimation. Br J Psychol 105(3):399–412. https://doi.org/10.1111/bjop.12046
Durbin CE, Klein DN, Hayden EP, Buckley ME, Moerk KC (2005) Temperamental emotionality in preschoolers and parental mood disorders. J Abnorm Psychol 114(1):28
Dvorak RD, Pearson MR, Day AM (2014) Ecological momentary assessment of acute alcohol use disorder symptoms: associations with mood, motives, and use on planned drinking days. Exp Clin Psychopharmacol 22(4):285–297. https://doi.org/10.1037/a0037157
Dvorak RD, Simons JS (2014) Daily associations between anxiety and alcohol use: variation by sustained attention, set shifting, and gender. Psychol Addict Behav 28(4):969–979. https://doi.org/10.1037/a0037642
Dvorak RD, Stevenson BL, Kilwein TM, Sargent EM, Dunn ME, Leary AV, Kramer MP (2018) Tension reduction and affect regulation: an examination of mood indices on drinking and non-drinking days among university student drinkers. Exp Clin Psychopharmacol 26(4):377–390. https://doi.org/10.1037/pha0000210
Emery NN, Simons JS (2020) The role of affect, emotion management, and attentional bias in young adult drinking: an experience sampling study. Psychopharmacology. https://doi.org/10.1007/s00213-020-05480-5
Emery NN, Carpenter RW, Treloar Padovano H, Miranda R Jr (2020) Why don’t they stop? Understanding unplanned marijuana use among adolescents and young adults. Psychol Addict Behav 34(5):579–589. https://doi.org/10.1037/adb0000561
Flannery BA, Poole SA, Gallop RJ, Volpicelli JR (2003) Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments. J Stud Alcohol 64(1):120–126
Fox CL, Towe SL, Stephens RS, Walker DD, Roffman RA (2011) Motives for cannabis use in high-risk adolescent users. Psychol Addict Behav 25(3):492
Garfield JBB, Lubman DI, Yücel M (2014) Anhedonia in substance use disorders: a systematic review of its nature, course and clinical correlates. Aust N Z J Psychiatry 48(1):36–51. https://doi.org/10.1177/0004867413508455
Geldhof GJ, Preacher KJ, Zyphur MJ (2014) Reliability estimation in a multilevel confirmatory factor analysis framework. Psychol Methods 19(1):72
Genĉöz T (2002) Discriminant validity of low positive affect: is it specific to depression? Personal Individ Differ 32(6):991–999. https://doi.org/10.1016/S0191-8869(01)00103-9
Gordon SM, Sterling R, Siatkowski C, Raively K, Weinstein S, Hill PC (2006) Inpatient desire to drink as a predictor of relapse to alcohol use following treatment. Am J Addict 15(3):242–245
Gossop M, Stewart D, Browne N, Marsden J (2002) Factors associated with abstinence, lapse or relapse to heroin use after residential treatment: protective effect of coping responses. Addiction 97(10):1259–1267. https://doi.org/10.1046/j.1360-0443.2002.00227.x
Gray JC, Padovano HT, Wemm SE, Miranda R Jr (2018) Predictors of topiramate tolerability in heavy cannabis using adolescents and young adults: a secondary analysis of a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol 38(2):134
Hall W, Lynskey M (2020) Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry 19(2):179–186
Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM (2013) DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry 170(8):834–851
Hoeppner BB, Kahler CW, Gwaltney CJ (2014) Relationship between momentary affect states and self-efficacy in adolescent smokers. Health Psychol 33(12):1507
Howard AL, Patrick ME, Maggs JL (2015) College student affect and heavy drinking: variable associations across days, semesters, and people. Psychol Addict Behav 29(2):430–443. https://doi.org/10.1037/adb0000023
Hussong AM (2007) Predictors of drinking immediacy following daily sadness: an application of survival analysis to experience sampling data [article]. Addict Behav 32(5):1054–1065. https://doi.org/10.1016/j.addbeh.2006.07.011
Jensen CD, Cushing CC, Aylward BS, Craig JT, Sorell DM, Steele RG (2011) Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J Consult Clin Psychol 79(4):433
Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial [article]. Lancet 361(9370):1677. https://doi.org/10.1016/S0140-6736(03)13370-3
Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME (2018) Monitoring the future national survey results on drug use: 1975–2017: overview, key findings on adolescent drug use. Institute for Social Research, The University of Michigan, Ann Arbor
Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36(7):980–988
Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24(2):97–129
Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29–53
Leventhal AM, Unger JB, Audrain-McGovern J, Sussman S, Volk HE, Strong DRJJopa (2015) Measuring anhedonia in adolescents: a psychometric analysis. J Pers Assess 97(5):506–514. https://doi.org/10.1080/00223891.2015.1029072
Marcotte D (1998) Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 50(2–3):245–251
Martin CS, Kaczynski NA, Maisto SA, Bukstein OM, Moss HB (1995) Patterns of DSM-IV alcohol abuse and dependence symptoms in adolescent drinkers. J Stud Alcohol 56(6):672–680
Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, Fanella F, Pozzi G, Iannoni E, D’Iddio SJPiN-P, Psychiatry, B (2011) Acetyl-l-carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Prog Neuro-Psychopharmacol Biol Psychiatry 35(4):953–958. https://doi.org/10.1016/j.pnpbp.2011.01.013
McCarthy DE, Curtin JJ, Piper ME, Baker TB (2010) Negative reinforcement: possible clinical implications of an integrative model. In Kassel JD (Ed.), Substance abuse and emotion. (pp. 15–42). Washington D.C.: American Psychological Association. https://doi.org/10.1037/12067-001
McDonald RP (2013) Test theory: a unified treatment. Psychology Press
McIntyre RS, Mancini DA, McCann S, Srinivasan J, Sagman D, Kennedy SH (2002) Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord 4(3):207–213
Merikangas KR, McClair VL (2012) Epidemiology of substance use disorders. Hum Genet 131(6):779–789
Miranda R Jr, Treloar H (2016) Emerging pharmacologic treatments for adolescent substance use: challenges and new directions. Curr Addict Rep 3(2):145–156. https://doi.org/10.1007/s40429-016-0098-7
Miranda Jr R, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J (2008) Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol: Clin Exp Res 32(3):489–497. https://doi.org/10.1111/j.1530-0277.2007.00592.x
Miranda R Jr, Treloar H, Blanchard A, Justus A, Monti PM, Chun T, Swift R, Tidey JW, Gwaltney CJ (2017) Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo-controlled pilot study [journal article]. Addict Biol 22(3):779–790. https://doi.org/10.1111/adb.12350
Mohr CD, Armeli S, Tennen H, Carney MA, Affleck G, Hromi A (2001) Daily interpersonal experiences, context, and alcohol consumption: crying in your beer and toasting good times. Journal of Personality and Social Psychology 80(3):489–500. https://doi.org/10.1037/0022-3514.80.3.489
Monti PM (2002) Treating alcohol dependence: a coping skills training guide. Guilford Press
Mowla A, Kardeh E (2011) Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial. Prog Neuropsychopharmacol Biol Psychiatry 35(4):970–973
Muthén LK, Muthén BO (2017) Mplus user’s guide (eighth edition ed.). Los Angeles, CA: Muthén & Muthén
Patrick ME, Bray BC, Berglund PA (2016a) Reasons for marijuana use among young adults and long-term associations with marijuana use and problems. J Stud Alcohol Drugs 77(6):881–888
Patrick ME, Yeomans-Maldonado G, Griffin J (2016b) Daily reports of positive and negative affect and alcohol and marijuana use among college student and nonstudent young adults. Subst Use Misuse 51(1):54–61
Pettit JW, Kline JP, Gencoz T, Gencoz F, Joiner TE Jr (2001) Are happy people healthier? The specific role of positive affect in predicting self-reported health symptoms. J Res Pers 35(4):521–536
Posner J, Russell JA, Peterson BS (2005) The circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathology. Dev Psychopathol 17(3):715–734
Ramirez J, Miranda R Jr (2014) Alcohol craving in adolescents: bridging the laboratory and natural environment. Psychopharmacology 231(8):1841–1851. https://doi.org/10.1007/s00213-013-3372-6
Ray LA, Miranda JR, Tidey JW, McGeary JE, MacKillop J, Gwaltney CJ, Rohsenow DJ, Swift RM, Monti PM (2010) Polymorphisms of the μ-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment [article]. J Abnorm Psychol 119(1):115–125. https://doi.org/10.1037/a0017550
Rohsenow DJ, Monti PM, Rubonis AV, Sirota AD, Niaura RS, Colby SM, Wunschel SM, Abrams DB (1994) Cue reactivity as a predictor of drinking among male alcoholics. J Consult Clin Psychol 62(3):620–626
Scott CK, Dennis ML, Gustafson DH (2018) Using ecological momentary assessments to predict relapse after adult substance use treatment. Addict Behav 83:116–122
Shrier LA, Ross CS, Blood EA (2014) Momentary positive and negative affect preceding marijuana use events in youth. J Stud Alcohol Drugs 75(5):781–789
Silins E, Swift W, Slade T, Toson B, Rodgers B, Hutchinson DM (2017) A prospective study of the substance use and mental health outcomes of young adult former and current cannabis users. Drug Alcohol Rev 36(5):618–625
Simons JS, Dvorak RD, Batien BD, Wray TB (2010) Event-level associations between affect, alcohol intoxication, and acute dependence symptoms: effects of urgency, self-control, and drinking experience. Addict Behav 35(12):1045–1053. https://doi.org/10.1016/j.addbeh.2010.07.001
Simons JS, Wills TA, Neal DJ (2014) The many faces of affect: a multilevel model of drinking frequency/quantity and alcohol dependence symptoms among young adults. J Abnorm Psychol 123(3):676–694. https://doi.org/10.1037/a0036926
Smith GT, Cyders MA (2016) Integrating affect and impulsivity: the role of positive and negative urgency in substance use risk. Drug Alcohol Depend 163:S3–S12
Snaith R, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P (1995) A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale. Br J Psychiatry 167(1):99–103
Sobell L, Sobell M (1992) Timeline follow-back: a technique for assessing self-reported alcohol consumption. In Measuring alcohol consumption: psychosocial and biochemical methods. Humana Press, New Jersey
Squeglia LM, Fadus MC, McClure EA, Tomko RL, Gray KM (2019) Pharmacological treatment of youth substance use disorders. J Child Adolesc Psychopharmacol 29(7):559–572
StataCorp (2017) Stata statistical software (Version 15) [Computer software]. StataCorp LP, College Station
Substance Abuse and Mental Health Services Administration (2019) Key substance use and mental health indicators in the United States: results from the 2018 national survey on drug use and health. Center for Behavioral Health, Rockville
Swendsen J, Burstein M, Case B, Conway KP, Dierker L, He J, Merikangas KR (2012) Use and abuse of alcohol and illicit drugs in US adolescents: results of the national comorbidity survey-adolescent supplement. Arch Gen Psychiatry 69(4):390–398. https://doi.org/10.1001/archgenpsychiatry.2011.1503
Tapert SF, Cheung EH, Brown GG, Frank LR, Paulus MP, Schweinsburg AD, Meloy MJ, Brown SA (2003) Neural response to alcohol stimuli in adolescents with alcohol use disorder. Arch Gen Psychiatry 60(7):727–735
Tiffany ST, Wray JM (2012) The clinical significance of drug craving. Ann N Y Acad Sci 1248(1):1–17
Treloar H, Miranda R (2017) Craving and acute effects of alcohol in youths’ daily lives: associations with alcohol use disorder severity. Exp Clin Psychopharmacol 25(4):303–313. https://doi.org/10.1037/pha0000133
Volkow ND, Koob GF, McLellan AT (2016) Neurobiologic advances from the brain disease model of addiction. N Engl J Med 374(4):363–371
Watson D, Clark LA (1999) The PANAS-X: manual for the positive and negative affect schedule-expanded form. University of Iowa, Iowa City
Wills TA, Sandy JM, Shinar O, Yaeger A (1999) Contributions of positive and negative affect to adolescent substance use: test of a bidimensional model in a longitudinal study. Psychol Addict Behav 13(4):327–338. https://doi.org/10.1037/0893-164X.13.4.327
Witkiewitz K, Marlatt GA, Walker D (2005) Mindfulness-based relapse prevention for alcohol and substance use disorders. J Cogn Psychother 19(3):211
Zautra AJ, Johnson LM, Davis MC (2005) Positive affect as a source of resilience for women in chronic pain. J Consult Clin Psychol 73(2):212–220. https://doi.org/10.1037/0022-006X.73.2.212
Funding
This research was supported in part by grants from National Institute on Alcohol Abuse and Alcoholism (L30AA027041, PI: Emery; AA007459, MPI: Monti, Miranda; AA028414, PI: Meisel; AA026326, PI: Miranda) and the National Institute on Drug Abuse (DA026778, PI: Miranda; DA016184, PI: Rohsenow).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Some data reported in this study were presented in other published articles. Most notably, the treatment outcomes of this randomized controlled trial were published elsewhere (Miranda et al. 2017). In addition, previous versions of these analyses were presented at the Annual Collaborative Perspectives on Addiction, April 4–6, 2019, Providence, Rhode Island.
This article belongs to a Special Issue on Cannabis and Cannabinoids
Rights and permissions
About this article
Cite this article
Emery, N.N., Carpenter, R.W., Meisel, S.N. et al. Effects of topiramate on the association between affect, cannabis craving, and cannabis use in the daily life of youth during a randomized clinical trial. Psychopharmacology 238, 3095–3106 (2021). https://doi.org/10.1007/s00213-021-05925-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-021-05925-5